Trial Profile
Increased risk of bleeding related complications in patients undergoing isolated on-pump coronary artery bypass grafting (CABG) treated with Ticagrelor or Clopidogrel
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Aug 2017
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Acute coronary syndromes
- Focus Adverse reactions; Therapeutic Use
- 22 Jul 2017 New trial record